Cryopyrin-associated periodic syndromes (CAPS) are characterized by life-long, recurrent symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue. Intermittent, disruptive exacerbations or flares can be triggered at any time by exposure to cooling temperatures, stress, exercise, or other unknown stimuli.
Skip to main content
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Arcalyst (Regeneron)
- INDICATIONS: Cryopyrin-associated periodic syndromes (CAPS) including familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS)
- CLASS: Fusion protein, Interleukin-1 inhibitor
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
anti-TNF agents, Lenalidomide, live vaccines, Natalizumab
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
